ResMed Inc.
ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications to diagnose, treat, and manage respiratory disorders in the United States and internationally. The company operates in two segments, Sleep and Breathing Health, and Residential Care Sof…
What to know about RMD
ResMed Inc. is a large Healthcare company with a mixed financial profile. It scores well on health and profitability, but size is worth keeping an eye on.
Should you consider RMD?
Based on 31 financial metrics and sector comparison. Not financial advice.
-
ResMed Inc. is a large-cap Healthcare company with a mixed overall financial profile — it ranks in the top quarter of its Healthcare peers (10 of 59).
-
The business is both profitable and financially healthy — it keeps a good portion of what it earns and carries its debt comfortably.
-
Valuation is in the middle of the pack — neither obviously cheap nor stretched.
-
The company is growing at a reasonable pace — not the fastest, but consistently moving in the right direction.
-
This stock pays no dividend — your return depends entirely on the share price rising over time.
-
Volatility is close to the S&P 500 average — typical market swings, nothing unusual.
-
This is a mixed picture — real strengths in some areas, but areas that need watching too. Do your homework on the sector before deciding.
At a glance
How it scores
We look at 31 different financial metrics and group them into categories. Here's how RMD compares to the other S&P 500 stocks.
Dive deeper — all 31 metrics 9 categories · valuation, growth, health, dividends & more Show all Hide
Valuation
Is the stock cheap or expensive relative to its earnings, sales, and assets? Lower multiples often mean better value.
| Metric | Value | vs S&P 500 |
|---|---|---|
| P/E Ratio (Trailing) | 18.17 | Above avg |
| Forward P/E | 15.56 | Above avg |
| PEG Ratio | 1.14 | Above avg |
| Price to Sales | 4.94 | Average |
| Price to Book | 4.21 | Average |
| EV/EBITDA | 12.89 | Above avg |
| Earnings Yield | 5.50% | Above avg |
Profitability
How efficiently does the company turn revenue into profit? Higher margins mean more money kept from each dollar earned.
| Metric | Value | vs S&P 500 |
|---|---|---|
| Gross Margin | 62.18% | Top 25% |
| Operating Margin | 35.33% | Top 25% |
| Net Profit Margin | 27.44% | Top 25% |
| Return on Equity | 25.25% | Above avg |
| Return on Invested Capital | 14.71% | Top 25% |
Growth
How fast is the business expanding? Strong growth in revenue and earnings signals increasing market demand.
| Metric | Value | vs S&P 500 |
|---|---|---|
| Revenue Growth (YoY) | 10.80% | Above avg |
| Revenue Growth (3Y CAGR) | 12.88% | Top 25% |
| EPS Growth (YoY) | 10.50% | Average |
| Free Cash Flow Growth | 28.34% | Above avg |
Health
Can the company cover its debts and obligations? A healthy balance sheet reduces the risk of financial trouble.
| Metric | Value | vs S&P 500 |
|---|---|---|
| Current Ratio | 3.01 | Top 25% |
| Debt to Equity | 0.13 | Top 25% |
| Interest Coverage | — | N/A |
| Altman Z-Score | 10.16 | Top 25% |
Dividends
Does the company pay shareholders, and is that payment growing and sustainable?
| Metric | Value | vs S&P 500 |
|---|---|---|
| Dividend Yield | — | N/A |
| Payout Ratio | — | N/A |
| Dividend Growth (5Y) | -5.83% | Above avg |
Cash Flow
Is real cash flowing into the business — not just accounting profits? Strong cash flow funds growth and dividends.
| Metric | Value | vs S&P 500 |
|---|---|---|
| Free Cash Flow Yield | 6.35% | Above avg |
| OCF to Sales | 34.13% | Top 25% |
Risk
How volatile is the stock compared to the broader market? Lower beta and volatility mean a smoother ride.
| Metric | Value | vs S&P 500 |
|---|---|---|
| Beta (1-Year) | 0.78 | Above avg |
| Volatility (30-Day) | 33.54% | Average |
Sentiment
What do analysts and short-sellers think? High analyst ratings and low short interest signal broad confidence.
| Metric | Value | vs S&P 500 |
|---|---|---|
| Short % of Float | 9.44% | Below avg |
| Avg. Analyst Rating | 2.05 | Average |
| Target Upside % | 40.98% | Top 25% |
Size
How large is the company by market value? Size affects stability, growth potential, and index inclusion.
| Metric | Value | vs S&P 500 |
|---|---|---|
| Market Capitalization | 27.36B | Average |
How does RMD compare to…?
Pick another stock and see them side by side in seconds.
You might also look at
Companies in a similar position to RMD — based on their financial profile.